Companies
Loading companies
Loading company profiles, tickers, sectors, and latest research coverage.
Loading company profiles, tickers, sectors, and latest research coverage.
Find company pages that collect related theses, catalysts, risks, filings, and discussion in one place.
Browse curated company pages by ticker, exchange, or research theme.
Acumen Pharmaceuticals (ABOS): the Alzheimer readout racing a cash clock
Open company ->Arbor Realty Trust (ABR): a servicing machine with credit cleanup still on the balance sheet
Open company ->Absci (ABSI): the hair-regrowth data bet hiding inside an AI drug-discovery platform
Open company ->Abbott (ABT): the diabetes-device machine now carrying a $20.6B cancer-diagnostics bet
Open company ->American Bitcoin (ABTC): the miner betting dilution can still grow sats per share
Open company ->Abits Group (ABTS): the tiny Tennessee Bitcoin miner with $84K of cash and a 760 PH/s ambition
Open company ->Arbutus (ABUS): the $179M settlement windfall hiding inside a pre-commercial HBV biotech
Open company ->ABVC BioPharma: zero revenue, $21M of assets, and a pipeline too wide for its cash balance
Open company ->Above Food (ABVE): the plant-protein pivot with a missing 20-F problem
Open company ->Abivax (ABVX): the ulcerative-colitis readout that has to carry a EUR 530M runway
Open company ->Abacus Global (ABX): the life-settlement flywheel that only works if the mortality math stays honest
Open company ->Arcosa (ACA): the infrastructure stock that sold its barge anchor before the grid boom
Open company ->Averin Capital (ACAA): the $284 million health-tech blank check with no company yet
Open company ->ACADIA (ACAD): two drugs, $1.25 billion guidance, and one Alzheimer readout that can change the stock
Open company ->Aurora Cannabis (ACB): the medical-cannabis turnaround trying to outrun dilution
Open company ->Acco Group (ACCL): the tiny compliance-services IPO that handed insiders 50-vote shares
Open company ->ACCO Brands: the school-supplies cash cow trying to outrun office-product decay
Open company ->ACCESS Newswire: the tiny PR platform betting its old compliance cash flow on subscriptions
Open company ->ProFrac: the electric-frac bet still chained to a billion-dollar balance sheet
Open company ->Adicet Bio: the lupus CAR-T readout racing a 2027 cash runway
Open company ->Acorn Energy: the tiny infrastructure monitor with 95% monitoring margins and one big customer question
Open company ->Arch Capital: the 82% combined-ratio machine with a $34 billion claims bill to keep honest
Open company ->Accendra Health: the home-care reset has $2.1 billion of debt in the exam room
Open company ->Acadia Healthcare: the mental-health boom with subpoenas in the chart
Open company ->